Keywords: serono, tests, serostim, hiv, lipodystrophy, swiss, biotechnology

Serono tests Serostim in HIV lipodystrophy

Article | 20 February 2001

Swiss biotechnology firm Serono has started a double-blind,placebo-controlled study to evaluate the activity of its human growth hormone Serostim ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Serostim

Nutropin

Somatropin

Nutropin AQ

Nutropin Depot

Go to drug listing